0B68 Kastenberg, David M - Thomas Jefferson University - Thomas Jefferson University

David M. Kastenberg, MD

Contact Dr. Kastenberg

132 South 10th Street
Main Building, Suite 480
Philadelphia, PA 19107

(215) 955-8900
(215) 503-2578 fax

Most Recent Peer-reviewed Publications

  1. Idiopathic myointimal hyperplasia of the mesenteric veins.
  2. Randomised clinical trial: Polyethylene glycol 3350 with sports drink vs. polyethylene glycol with electrolyte solution as purgatives for colonoscopy - The incidence of hyponatraemia
  3. A multicenter, prospective, randomized comparison of a novel signal transmission capsule endoscope to an existing capsule endoscope
  4. The effect on colon visualization during colonoscopy of the addition of simethicone to polyethylene glycol-electrolyte solution: A randomized single-blind study
  5. Refractory pancolitis: A novel presentation of idiopathic myointimal hyperplasia of mesenteric veins
  6. Pulmonary capillaritis: A rare extra-intestinal manifestation of inflammatory bowel disease
  7. Efficacy of morning-only compared with split-dose polyethylene glycol electrolyte solution for afternoon colonoscopy: A randomized controlled single-blind study
  8. Rectal Perforation by Retroflexion of the Colonoscope Managed by Endoclip Closure
  9. An Unusual Cause of Hematemesis
  10. A validation study of 3 grading systems to evaluate small-bowel cleansing for wireless capsule endoscopy: a quantitative index, a qualitative evaluation, and an overall adequacy assessment
  11. Complete resolution of gastric amyloidosis after autologous stem cell transplantation.
  12. Is single-cell apoptosis sufficient for the diagnosis of graft-versus-host disease in the colon?
  13. Providing an endoscopy report to patients after a procedure: a low-cost intervention with high returns
  14. Adenocarcinoma of the prostate presenting as an obstructing rectal mass
  15. Capsule endoscopy diagnosis of radiation enteritis in a patient previously considered to have celiac sprue.
  16. Tolerability and patient acceptance of sodium phosphate tablets compared with 4-L PEG solution in colon cleansing: Combined results of 2 identically designed, randomized, controlled, parallel group, multicenter phase 3 trials
  17. A novel PEG 3350 formulation
  18. Quantity of sodium and phosphate in Visicol® tablet and Fleet® Phospho-soda® liquid bowel preparations [2] (multiple letters)
  19. Safety of sodium phosphate tablets in patients receiving propofol-based sedation for colonoscopy.
  20. Safety of sodium phosphate for colonoscopy [1] (multiple letters)